Dokument: Resorbable Patient-Specific Implants of Molybdenum for Pediatric Craniofacial Surgery—Proof of Concept in an In Vivo Pilot Study
| Titel: | Resorbable Patient-Specific Implants of Molybdenum for Pediatric Craniofacial Surgery—Proof of Concept in an In Vivo Pilot Study | |||||||
| URL für Lesezeichen: | https://docserv.uni-duesseldorf.de/servlets/DocumentServlet?id=68427 | |||||||
| URN (NBN): | urn:nbn:de:hbz:061-20250204-100934-1 | |||||||
| Kollektion: | Publikationen | |||||||
| Sprache: | Englisch | |||||||
| Dokumententyp: | Wissenschaftliche Texte » Artikel, Aufsatz | |||||||
| Medientyp: | Text | |||||||
| Autoren: | Hoppe, Dominik Thomas [Autor] Toschka, André [Autor] Karnatz, Nadia [Autor] Moellmann, Henriette L. [Autor] Seidl, Maximilian [Autor] Meenen, Lutz van [Autor] Poehle, Georg [Autor] Redlich, Christian [Autor] Rana, Majeed [Autor] | |||||||
| Dateien: |
| |||||||
| Stichwörter: | biocompatible, patient-specific, implant, resorbable, oral and maxillofacial surgery, metallic, pediatrics, cranioplasty, craniosynostosis, molybdenum | |||||||
| Beschreibung: | Titanium continues to be the gold standard in the field of osteosynthesis materials. This also applies to pediatric craniofacial surgery. Various resorbable materials have already been developed in order to avoid costly and risky second operations to remove metal in children. However, none of these resorbable materials have been able to completely replace the previous gold standard, titanium, in a satisfactory manner. This has led to the need for a new resorbable osteosynthesis material that fulfills the requirements for biocompatibility, stability, and uniform resorption. In our previous in vitro and in vivo work, we were able to show that molybdenum fulfills these requirements. To further confirm these results, we conducted a proof of concept in four domestic pigs, each of which was implanted with a resorbable molybdenum implant. The animals were then examined daily for local inflammatory parameters. After 54 days, the animals were euthanized with subsequent computer tomography imaging. We also removed the implants together with the surrounding tissue and parts of the spleen, liver, and kidney for histopathological evaluation. The molybdenum implants were also analyzed metallographically and using scanning electron microscopy. A blood sample was taken pre- and post-operatively. None of the animals showed clinical signs of inflammation over the entire test period. Histopathologically, good tissue compatibility was found. Early signs of degradation were observed after 54 days, which were not sufficient for major resorption. Resorption is expected with longer in situ residence times based on results of similar earlier investigations. | |||||||
| Rechtliche Vermerke: | Originalveröffentlichung:
Hoppe, D. T., Toschka, A., Karnatz, N., Möllmann, H., Seidl, M., van Meenen, L., Poehle, G., Redlich, C., & Rana, M. (2024). Resorbable Patient-Specific Implants of Molybdenum for Pediatric Craniofacial Surgery—Proof of Concept in an In Vivo Pilot Study. Journal of Functional Biomaterials, 15(5), Article 118. https://doi.org/10.3390/jfb15050118 | |||||||
| Lizenz: |  Dieses Werk ist lizenziert unter einer Creative Commons Namensnennung 4.0 International Lizenz | |||||||
| Fachbereich / Einrichtung: | Medizinische Fakultät | |||||||
| Dokument erstellt am: | 04.02.2025 | |||||||
| Dateien geändert am: | 04.02.2025 |
